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SINCE THE INTRODUCTION OF CEL-lular telephone service in theUnited States in 1984,1 the num-ber of subscribers has in-
creased substantially every year. By the
end of 1999, there were more than 86
million cellular telephone users.2 Cel-
lular telephones, which include hand-
held or mobile telephones, car tele-
phones, and portable or bag telephones,
operate on radiofrequency (RF) sig-
nals in the 800- to 900-MHz range.
Concerns have been raised about pos-
sible adverse health effects due to expo-
sure to these signals. In particular, alle-
gations that the use of handheld cellular
telephones causes brain cancer3 are based
on the close proximity of the antenna,
which is incorporated into the tele-
phone receiver, to the head of the user.4,5
These claims cannot be strongly sup-
ported or refuted because of the relative
paucity of scientific data on this topic.
The most highly exposed cranial areas
fromhandheldcellular telephonesare the
ipsilateral ear and cheek regions. The ab-
sorption of RF energy in the brain de-
creases with distance from the ipsilat-
eral ear.6 There is less concern over
intracranial RF exposure from a car-
mounted telephone because the an-
tenna is mounted on the roof and the ve-
hicle acts as a shield. Portable cellular
telephones, which are relatively uncom-
mon, are another source of RF emis-
sions, but because the antenna is con-
tained in a carrying case, the exposure
is not localized to the head.
The use of cellular telephones is one
of several suspected risk factors for brain
cancer, although the causes of this dis-
ease remain poorly understood. Predis-
posing genetic disorders and prior cra-
nial radiotherapy account for a small
percentage of cases. There is little evi-
dence that the risk depends on ciga-
rette smoking and alcohol consump-
tion, and inconsistent findings have been
reported for various environmental, oc-
cupational, and dietary exposures.7,8 The
health effects due to using cellular tele-
phones are currently being studied in a
number of populations. In preliminary
reports of a case-control study con-
ducted in Sweden, the risk of brain can-
cer was unrelated to using a handheld
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Context A relative paucity of data exist on the possible health effects of using cel-
lular telephones.
Objective To test the hypothesis that using handheld cellular telephones is related
to the risk of primary brain cancer.
Design and Setting Case-control study conducted in 5 US academic medical cen-
ters between 1994 and 1998 using a structured questionnaire.
Patients A total of 469 men and women aged 18 to 80 years with primary brain
cancer and 422 matched controls without brain cancer.
Main Outcome Measure Risk of brain cancer compared by use of handheld cel-
lular telephones, in hours per month and years of use.
Results The median monthly hours of use were 2.5 for cases and 2.2 for controls.
Compared with patients who never used handheld cellular telephones, the multivar-
iate odds ratio (OR) associated with regular past or current use was 0.85 (95% con-
fidence interval [CI], 0.6-1.2). The OR for infrequent users (,0.72 h/mo) was 1.0 (95%
CI, 0.5-2.0) and for frequent users (.10.1 h/mo) was 0.7 (95% CI, 0.3-1.4). The mean
duration of use was 2.8 years for cases and 2.7 years for controls; no association with
brain cancer was observed according to duration of use (P=.54). In cases, cerebral
tumors occurred more frequently on the same side of the head where cellular tele-
phones had been used (26 vs 15 cases; P=.06), but in the cases with temporal lobe
cancer a greater proportion of tumors occurred in the contralateral than ipsilateral side
(9 vs 5 cases; P=.33). The OR was less than 1.0 for all histologic categories of brain
cancer except for uncommon neuroepitheliomatous cancers (OR, 2.1; 95% CI, 0.9-4.7).
Conclusions Our data suggest that use of handheld cellular telephones is not as-
sociated with risk of brain cancer, but further studies are needed to account for longer
induction periods, especially for slow-growing tumors with neuronal features.
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cellular telephone.9,10 Thehypothesis that
handheld cellular telephone use is asso-
ciated with primary brain cancer was
tested in the current hospital-based
study.
METHODS
Patients between the ages of 18 and 80
years were interviewed using a struc-
tured questionnaire between 1994 and
early 1998 in New York, NY (Memo-
rial Sloan-Kettering Cancer Center,
New York University Medical Center,
Columbia University Presbyterian Hos-
pital), Providence, RI (Rhode Island
Hospital), and Boston, Mass (Massa-
chusetts General Hospital). A descrip-
tion of each type of cellular telephone
(handheld, bag, car) was provided, and
patients were asked if they had ever
used a handheld cellular telephone on
a regular basis (regular defined as hav-
ing had a subscription to cellular tele-
phone service). Information was ob-
tained on the number of years of use,
minutes/hours used per month, year of
first use, manufacturer, and reported av-
erage monthly bill. Data on which hand
was used to hold the cellular tele-
phone was collected from 700 (78.6%)
of the 891 patients. Requests were made
to obtain billing records from the cel-
lular telephone carrier in New York, in
collaboration with Epidemiology Re-
sources Inc (Newton, Mass). These ef-
forts were unsuccessful and subse-
quently the patient was asked to
estimate the average monthly cellular
telephone bill (102 [71.8%] of the 142
handheld cellular telephone users).
Other questionnaire items included de-
mographics, smoking history, alcohol
consumption, exposure to power fre-
quency fields, occupation, and medi-
cal history. The interview was de-
signed to last for about a half hour to
ensure a high response rate and avoid
patient fatigue. A dietary assessment
was not conducted.
Collaboration was sought with on-
cologists, neurosurgeons, nursing, and
other staff. The research interviewers
were health professionals or health pro-
fessionals in training. They were ac-
tively involved in the identification of
eligible patients and consequently were
knowledgeable about patients’ medi-
cal conditions. The interviewers con-
sulted with the hospital staff to deter-
mine the most appropriate time to
approach patients. Eligible case pa-
tients (cases) were those diagnosed as
having primary brain cancer within the
past year (International Classification of
Diseases, Ninth Revision, Clinical Modi-
fication [ICD-9-CM] codes 191.0-
191.9 [70% interviewed in the same
month or within 2 months of diagno-
sis]) and spoke English. The histo-
logic type and the anatomic location of
the tumor were obtained from pathol-
ogy and magnetic resonance imaging re-
ports.
Eligible control patients (controls)
were inpatients from the same hospi-
tals as the cases and identified from
daily admission rosters. Controls were
admitted for benign conditions, except
at 2 study centers, which included
predominately cancer patients (Me-
morial Sloan-Kettering Cancer Center
and Massachusetts General Hospital).
Patients diagnosed as having lym-
phoma or leukemia were not eligible
for inclusion because these conditions
are possibly linked to exposure from
RF fields. In addition to matching by
hospital, controls were frequency
matched on a 1:1 ratio by age (± 5
years), sex, race, and month of admis-
sion. The list of the previous day’s
hospital admissions was obtained from
the admissions office each morning.
The admission list was reviewed
sequentially and the first patient who
met the eligibility criteria and was an
appropriate match to a case was
approached. An unmatched case
remained in the study. To further con-
firm the patient’s eligibility, the medi-
cal record was reviewed. All patients
signed a consent form approved by the
institutional review board of Memorial
Sloan-Kettering Cancer Center (New
York, NY). In the first year of the
study, 43 of the case interviews and 6
of the control interviews were con-
ducted with proxies. In subsequent
years, all interviews were done with
the patients.
Statistical Analysis
The Spearman correlation coefficient
was calculated to measure the relation-
ship between the monthly hours of
handheld cellular telephone use and the
reported monthly bill. For 17 patients
whose employer paid the bill, the
monthly bill was adjusted by the esti-
mated percentage of use. The relation-
ship between the frequency and the du-
ration of telephone use was measured
by the Pearson correlation coefficient.
The relative risk of brain cancer asso-
ciated with regular use of a handheld
cellular telephone was estimated by the
odds ratio (OR) and 95% confidence in-
terval (CI). To determine if this asso-
ciation varied by study center, the crude
OR was compared with the Mantel-
Haenszel pooled summary OR. A strati-
fied analysis was conducted by exam-
ining several suspected risk factors to
identify potential confounders.
Three exposure measures were used
for OR calculations: hours per month,
years of use, and lifetime cumulative
hours (hours of cellular telephone use
per month multiplied by the number
of years of use). These measures were
grouped into 4 categories (3 catego-
ries for years of use) based on the dis-
tribution within the controls. Uncon-
ditional logistic regression analysis was
conducted to derive the OR associated
with each exposure level relative to the
reference group of nonusers, while si-
multaneously adjusting for the match-
ing factors, type of respondent (sub-
ject vs proxy), and other possible
confounders. The interview date
(month and year) was included in the
model as a single continuous term. A
test for trend was conducted by using
the median quantile value as the expo-
sure score in the logistic regression
model. The reported P values for the
trend tests are 2-sided. Nonparamet-
ric regression analyses were also con-
ducted as an alternative method for as-
sessing a dose-response relationship.
This technique has become increas-
ingly popular in retrospective studies
since the categorization of the expo-
sure variable into quantiles is an arbi-
trary method that could potentially
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mask possible exposure affects within
a category.11 Restricted cubic splines
with 3 prespecified knots positioned on
the quartile boundary points were fit-
ted using SAS/IML software12 for each
measure of cellular telephone use, con-
trolling for the same covariates in the
logistic regression models.13
Exploratory subset analyses were
conducted by histologic groups based
on ICD-9-CM codes and International
Agency for Research on Cancer group-
ings,14 and by the anatomic location of
the brain lesion. The entire control set
was used as the comparison group for
both histologic and anatomic-specific
subset analyses. In an analysis that was
limited to just the cases who used cel-
lular telephones, the x2 test was con-
ducted to determine whether the pro-
portion of all cerebral tumors that were
left-sided vs right-sided differed by cel-
lular telephone handedness (right vs left
hand).
RESULTS
Of 571 eligible cases who were ap-
proached, 469 (82%) were success-
fully interviewed. There were 2 deaths,
25 refusals, and 75 who consented but
were too ill to participate or were un-
communicative. In addition, 55 cases
were not approached because of ill-
ness and 42 were excluded because En-
glish was not their spoken language.
The response rate in the controls was
90%; half of the nonrespondents were
refusals and half were unsuccessful in-
terviews. A matched control was not
found for all cases, especially those
younger than 30 years. The matching
requirement by the month of admis-
sion precluded adding additional con-
trols at the end of the study, which
could have biased the findings. The av-
erage date of interview occurred 5
months earlier for cases than controls.
The ages, years of education, and
types of occupations were similar for
the 469 cases and 422 controls
(TABLE 1). Sixty-six cases (14%) and 76
controls (18%) reported using hand-
held cellular telephones (Table 1). In
all subjects, cellular telephones were
used more frequently by men than
women, subjects aged 30 to 59 years,
and salespersons. In most age, sex, race,
and occupational groups, handheld cel-
lular telephones were used about the
same or slightly more frequently in both
groups. In patients with less than 12
years of education, cellular tele-
phones were used more often by con-
trols than cases (17.7% vs 2.6%).
In the controls, there was little dif-
ference in the use of handheld cellular
telephones by disease category except
for cancer patients (TABLE 2). The lower
user rate in cancer controls reflects their
older mean age. For the age group of
60 years and older, cancer controls and
other controls used cellular tele-
phones at about the same rate (4.1% vs
5.6%). Of the 50 cancer controls who
were younger than 60 years, 4 (8%)
used cellular telephones, including 1
(8.3%) of 12 patients with gastrointes-
tinal tract cancers, 1 (14.3%) of 7 with
lung cancer, 1 (16.7%) of 6 with fe-
male reproductive cancers, and 1 (20%)
of 5 with melanoma.
Three patients reported first using a
handheld cellular telephone between
1980 and 1983; this date was recoded to
1984. Four cases and 1 control did not
provide information on the frequency of
use. All patients who used cellular tele-
phones were current users, except for 4
patients who quit a year or more ago. The
Table 1. Characteristics of Case and Control Patients, 1994-1998
Characteristic*






Total 469 66 (14.1) 422 76 (18.0)
Sex
Men 304 (64.8) 44 (14.5) 271 (64.2) 57 (21.0)
Women 165 (35.2) 22 (13.3) 151 (35.8) 19 (12.6)
Age, y
,30 56 (11.9) 9 (16.1) 48 (11.4) 7 (14.6)
30-39 86 (18.3) 16 (18.6) 74 (17.6) 21 (28.4)
40-49 103 (22.0) 20 (19.4) 100 (23.7) 21 (21.0)
50-59 99 (21.1) 16 (16.1) 79 (18.7) 21 (26.6)
$60 125 (26.7) 5 (4.0) 121 (28.7) 6 (5.0)
Total education, y
,12 39 (8.3) 1 (2.6) 34 (8.0) 6 (17.7)
12 101 (21.5) 12 (11.9) 76 (18.1) 9 (11.8)
13-15 95 (20.3) 22 (23.2) 86 (20.4) 16 (18.6)
$16 234 (49.9) 31 (13.3) 226 (53.6) 45 (19.9)
Race
White 460 (98.1) 64 (13.9) 412 (97.6) 74 (18.0)
Other 9 (1.9) 2 (22.2) 10 (2.4) 2 (20.0)
Occupation
Professional 144 (30.7) 18 (12.5) 139 (32.9) 20 (14.4)
Managerial 71 (15.1) 12 (16.9) 75 (17.8) 22 (29.3)
Sales 46 (9.8) 8 (17.4) 38 (9.0) 12 (31.6)
Clerical 65 (13.9) 11 (16.9) 49 (11.6) 7 (14.2)




50 (10.7) 4 (8.0) 36 (8.5) 6 (16.7)
Household 25 (5.3) 3 (12.0) 26 (6.2) 0 (0)
*Hospital distribution of patients (cases/controls): New York University (216/225); Memorial Sloan-Kettering Cancer
Center (99/65); New York Presbyterian (66/67); Massachusetts General (55/41); and Rhode Island Hospital (33/24).
Table 2. Handheld Cellular Telephone Use
in Controls by Diagnostic Category
Diagnostic
Category
No. (%) of Controls
Who Ever Used a
Cellular Telephone
Malignant neoplasm 99 (6.1)
Musculoskeletal disorder 71 (23.7)
Skin condition 19 (15.8)
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correlation between the amount of cel-
lular telephone use and the associated
monthly bill was 0.58 (P,.01). For the
18 patients who had switched from 1
brand of handheld cellular telephone to
the current brand, the correlation be-
tween the first handheld cellular tele-
phone that was used and its correspond-
ing monthly bill was 0.36 (P=.15).
The crude OR for brain cancer and
regular handheld cellular telephone use
was 0.74 (95% CI, 0.50-1.10) relative
to nonusers. There was little heteroge-
neity in the hospital-specific ORs; the
Mantel-Haenszel OR was 0.79 (95% CI,
0.60-1.10). In stratified analysis, the risk
was calculated according to cigarette
smoking status, alcohol consumption,
and several proxy measures of electro-
magnetic field exposure (residence near
a power station or high-voltage trans-
former; use of household electrical
equipment, such as electric hair dryer,
electric razor). There were few differ-
ences in the stratum-specific esti-
mates. Few patients were ham radio op-
erators or were occupationally exposed
to RF fields due to sources other than
cellular telephones (,1%).
The mean duration of handheld cel-
lular telephoneusewas2.8years forcases
and 2.7 years for controls. The multi-
variate OR associated with ever use of a
handheldcellulartelephonewas0.8(95%
CI, 0.6-1.2). When examined by dura-
tion of use, the OR was 0.7 (95% CI, 0.4-
1.3) for 1 year of use and 0.7 (95% CI,
0.4-1.4) for 4 or more years of use
(TABLE 3). The median monthly hours
of use were 2.5 for cases and 2.2 for con-
trols. There were little differences in the
risk according to the frequency of cel-
lular telephone use. The OR was 1.00
(95%CI,0.50-2.00)associatedwithinfre-
quent use (,three fourths per hour per
month)and0.70(95%CI,0.30-1.40) for
frequent use (.10.1 hours of a month).
The correlation between the number of
hours and the number of years of cellu-
lar telephone use was 0.34 (P,.01).
Using the cumulative exposure mea-
sure, the risk of brain cancer was also
below 1 for all 4 exposure categories
(Table 3). The estimated coefficients for
theslopeof the3exposuremeasureswere
negative, but the trend test values were
not statistically significant.
The dose-response assessment using
cubic splines gave results similar to that
obtained from logistic regression analy-
sis. The FIGURE shows the nonparamet-
ric regression curve for the relation-
ship between lifetime hours of handheld
cellular telephone use and brain cancer
with knot positions at 8.7, 60, and 480
hours. The risk is estimated to be be-
low 1 for nearly the entire range of ob-
served exposure values but the corre-
sponding 95% CIs for the risk values
include 1.0. Changing the number of
knots or knot position did not substan-
tially alter the results. The cubic splines
plotted for current frequency and du-
ration of use were also similar to the re-
sults obtained by logistic regression in
Table 3 (data not shown).
In handheld cellular telephone us-
ers, 86% of cases and 85% of controls re-
ported usually extending the antenna
during telephone calls. Of the 31 pa-
tients who switched from one brand of
handheld cellular telephone to an-
other, 8 (88.9%) of 9 cases and 12
(63.2%) of 19 controls reported usually
extending the antenna when using the
previous cellular telephone (3 missing
observations; P=.16). Eighty-eight per-
cent of all handheld cellular telephones
were analog telephones. There were no
case-control differences in the percent-
age who used digital telephones. There
were also little case-control differences
in the brand (manufacturer) of cellular
telephone used. More than 50% of both
cases and controls who used cellular tele-
phones reported using 1 specific brand.
In case patients, the most common
tumor site was the frontal lobe, fol-
lowed by the temporal and parietal
lobes. The risk of brain cancer in asso-
ciation with cellular telephone use was
1.1 or less for all brain sites (TABLE 4).
Information on cellular telephone
handedness was obtained for 56 of the
66 cases who used handheld cellular
Figure. Nonparametric Regression Curve,
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0 403 (85.9) 346 (82.0) 1.0
1† 21 (4.5) 30 (7.1) 0.7 (0.4-1.3) .54
2-3 28 (6.0) 24 (5.7) 1.1 (0.6-2.0)
$4 17 (3.6) 22 (5.2) 0.7 (0.4-1.4)
No. of hours/month
0 403 (86.7) 346 (82.2) 1.0
.0-#0.72 19 (4.1) 20 (4.8) 1.0 (0.5-2.0)
.0.72-#2.1 10 (2.2) 17 (4.0) 0.5 (0.2-1.2) .27
.2.1-#10.1 20 (4.3) 18 (4.3) 0.9 (0.5-1.9)
.10.1 13 (2.8) 20 (4.8) 0.7 (0.3-1.4)
No. of cumulative hours‡
0 403 (86.7) 346 (82.2) 1.0
.0-#8.7 17 (3.7) 18 (4.3) 1.0 (0.5-2.0)
.8.7-#60 12 (2.6) 19 (4.5) 0.6 (0.3-1.3) .30
.60-#480 19 (4.1) 19 (4.5) 0.9 (0.5-1.8)
.480 14 (3.0) 19 (4.5) 0.7 (0.3-1.4)
*Adjusted for age, years of education, sex, race, study center, proxy subject, and month and year of interview.
†Four cases used a cellular telephone for half a year.
‡Four cases and 1 control had missing data on frequency of use.
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telephones. Five of the 56 cases re-
ported no hand preference, and tumor
laterality was not specified in an addi-
tional 9 cases. One case had a brain-
stem tumor. Of the remaining 41 cases,
26 usually used the cellular telephone
on the same side of the head where the
tumor occurred, compared with 15 who
used the telephone on the contralateral
side (P=.06). Of 14 cases with tempo-
ral lobe cancer that used cellular tele-
phones, 5 were on the ipsilateral side and
9 were on the contralateral side (P=.33).
The histologic-specific risk esti-
mates associated with handheld cellu-
lar telephone use are shown in TABLE 5.
Gliomas, which are composed of neo-
plastic glial cells, include astrocytic tu-
mors, oligodendrogliomas, and other
types that can be classified by patho-
logic distinction and location. Neuro-
epitheliomatous (neuronal) cancers are
rare tumors composed of ganglion cells,
usually in combination with neoplas-
tic glial cells. The OR for astrocytic tu-
mors was 0.8 (95% CI, 0.5-1.2). The OR
for neuroepitheliomatous cancers was
2.1 (95% CI, 0.9-4.7). Of the 35 cases
with neuroepitheliomatous cancers, 10
were located in the temporal lobe and
4 of these 10 used cellular telephones.
For both the glioma and neuronal his-
tological types, a significant trend in the
OR was not found with increased cu-
mulative exposure.
COMMENT
The use of handheld cellular tele-
phones was unrelated to the risk of brain
cancer in the current study. The over-
all OR was less than 1.0, but the lack of
a trend in the data does not support the
interpretation of a protective effect. In
other studies of cellular telephone use
and brain cancer, the risk of various ma-
lignant and benign brain tumors was
0.98 (95% CI, 0.69-1.41) in a popula-
tion-based study of 233 cases in Swed-
ish.9,10 A nonsignificant 2-fold risk was
reported for ipsilateral temporal lobe tu-
mors, however this association cannot
be calculated independently from the
published tables in the Sweden ar-
ticles. In a cohort of 255868 car, hand-
held, and other cellular telephone us-
ers, the standardized mortality rate for
brain cancer was 3.7 in persons who
used handheld cellular telephones for
less than 2 minutes per day, compared
with 2.0 for car telephone users after 1
year of follow-up (CIs not calculated)
based on 2 and 4 deaths, respectively.15
There were no deaths due to brain can-
cer in persons who used handheld cel-
lular telephones for longer durations. A
multinational case-control study of brain
cancer has begun in 8 countries,16 and
in Denmark cellular telephone subscrip-
tion information is being linked to a na-
tional death index.17 In the United States,
another hospital-based study of brain
cancer was recently completed.18
Ithasbeenspeculated that the increas-
ing age-adjusted incidence of brain can-
cer(inAustralia)since1982isduetoana-
log cellular telephone use,19 although





US brain cancer rates between 1975 and
1995 increased only in persons aged 70
years and older, and that this trend was
likely due to improvements in diagno-
sis. This study and other surveys22 found
that cellular telephone use is relatively
uncommon in the elderly.
Epidemiologic methods use surro-
gate measures of exposure to character-
ize cellular telephone RF exposure. In-
dividual exposure levels due to cellular
telephone emissions vary by cellular size,
Table 4. Odds Ratios for Brain Cancer and Handheld Cellular Telephone Use by Anatomic
Location*
Brain Cancer Site
No. (%) Who Ever




Frontal lobe 126 (19.8) 1.1 (0.7-2.0)
Parietal lobe 60 (10.0) 0.8 (0.3-2.0)
Occipital lobe 21 (9.5) 0.8 (0.2-4.0)
Temporal lobe 108 (16.7) 0.9 (0.5-1.7)
Cerebrum (not lobes) 36 (7.4) 0.3 (0.1-1.1)
Cerebellum 8 (12.5) 0.9 (0.1-8.1)
Brainstem/ventricular/other 25 (16.0) 0.9 (0.3-2.8)
Unspecified 85 (9.4) 0.9 (0.4-2.2)
*Based on the International Classification of Diseases, Ninth Revision, Clinical Modification.
†Adjusted for age, years of education, sex, race, study center, proxy subject, and month and year of interview. Odds
ratio calculations were determined by comparing each case subgroup with all controls.












Astrocytic 354 (75.5) 41 (11.6) 0.8 (0.5-1.2)
Glioblastoma (M9440) 244 (52.0) 29 (11.9) NA
Astrocytoma (M9400-9421) 82 (17.5) 7 (8.5) NA
Other glioma (M9380) 28 (6.0) 5 (17.9) NA
Oligodendroglioma/mixed glioma
(M9450-9451, 9382)
55 (11.7) 9 (16.4) 0.9 (0.4-2.1)
Ependymal (M9391-9394) 8 (1.7) 0 (0) NA
Choroid plexus (M9390) 1 (0.2) 0 (0) NA
Other (M9362, 9064, 9161) 6 (1.3) 1 (16.7) NA
Not specified 10 (2.1) 1 (10.0) NA
Neuroepitheliomatous (M9490-9523)‡ 35 (7.5) 14 (40.0) 2.1 (0.9-4.7)
*ICD-9-CM indicates International Classification of Diseases, Ninth Revision, Clinical Modification.
†Adjusted for age, years of education, sex, race, study center, proxy subject, and month and year of interview. Odds
ratio calculations were determined by comparing each case subgroup with all controls. NA indicates not applicable.
‡Includes 18 gangliogliomas, 11 ganglioglioblastomas, 4 neurocytomas, and 2 neuroepitheliomas.
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amount of cellular telephone traffic, qual-
ity of the transmission, antenna exten-
sion, handset dimensions, and other fac-
tors. The deposition of cellular telephone
RF energy in the head, however, de-
pends on complex interactions of RF
fields with biological tissue.6,23 The RF
energy that is absorbed in biological tis-
sue is not highly correlated with radi-
ated energy.24,25 Consequently, the rate
of total electromagnetic energy absorp-
tion in tissue is measured by the spe-
cific absorption rate using probes in
phantom head models. In simulation
studies involving cellular telephones
placed to the ear, intracranial absorp-
tion of RF energy dissipates rapidly with
distance from the cellular telephone an-
tenna.26 The specific absorption rate on
the contralateral side is a small fraction
of the exposure on the ipsilateral side,
with the highest intracranial exposure in
brain tissue behind the ipsilateral ear.27
In humans, this region corresponds to
the temporal lobe. In the current study,
tumors were more likely to occur on the
ipsilateral side of the head, but tumors
in the temporal lobe were somewhat
more likely to occur on the contralat-
eral side. The laterality of the tumor in
relationship with cellular telephone
handedness was not statistically signifi-
cant in either case.
Several biases were considered when
interpreting the current findings. The
use of cellular telephones in nonrespon-
dents and in the 57 cases who were not
approached might have differed from
participating cases. In general, the se-
verity of illness was greater in case than
control patients, and consequently the
recent use of cellular telephones in cases
might have been overstated if disease
symptoms resulted in a decline in the
number of recent cellular telephone calls.
The data also showed that the cellular
telephone user rate was substantially
lower in the 39 case patients who had
not completed high school compared
with controls with the same level of edu-
cation. This could reflect a recall bias in
case patients with fewer years of educa-
tion or reflect a selection bias. How-
ever, nearly all cellular telephone users
in this study were current users and it
seems unlikely that recall bias could have
been substantial. There was a moder-
ate correlation between the estimated av-
erage monthly bill and the amount of cel-
lular telephone use, which provides
some assurance that cellular telephone
usage patterns were described with rea-
sonable accuracy. In a population-
based survey, the correlation between re-
ported cellular telephone use and actual
3-month billing records was 0.74.28
The choice of hospital controls, rather
than a probability sample of the gen-
eral population, could have introduced
bias if the patient’s medical condition
was associated with using a handheld
cellular telephone. For instance, con-
trol patients younger than 60 years with
specific cancers used cellular tele-
phones less frequently than other con-
trols in this age group. Different refer-
ral patterns between cases and controls
could have also introduced bias. Al-
though 93% of cases and 92% of con-
trols treated at the New York study cen-
ters lived in New York or New Jersey,
there might have been differences in lo-
cal referral patterns. However the per-
centage of all controls who used cellu-
lar telephones (18%) during the study
period of 1994 to 1998 seems consis-
tent with commercial subscription data
(about 25% of total US population in
1998). None of the controls were
admitted for injuries resulting from
motor vehicle crashes or events associ-
ated with cellular telephone owner-
ship.15,29,30 The age and sex distribution
of controls who used cellular tele-
phones in this study (Table 2) was simi-
lar to a demographic study of 256284
cellular telephone users in 4 large Ameri-
can cities.22 In both studies, men were
twice as likely to use cellular tele-
phones as women. More than 9% of
handheld cellular telephone users in this
study reported no telephone hand pref-
erence, compared with 10% of users who
reported switching hands in a survey of
3157 cellular telephones users.28
The validity of the case-control find-
ings also depends on the exposure pre-
ceding the disease, but the onset for
some brain tumors might have pre-
dated clinical diagnosis by several
months or possibly by years. Most glio-
mas exhibit rapid tumor growth, al-
though growth rates vary. Low-grade
diffuse astrocytomas and ganglioglio-
mas are characterized by slow-growth
rates and are well differentiated. Evi-
dence for a long latency for some brain
tumors comes from findings of asymp-
tomatic brain cancer detected in healthy
individuals serving as controls for stud-
ies involving magnetic resonance im-
aging screening.31
The positive association between
handheld cellular telephone use and
neuroepitheliomatous cancers re-
quires careful interpretation given re-
cent changes in the morphologic crite-
ria for brain cancer.32 There is little
diagnostic distinction between some
gangliogliomas, the most common form
of neuroepitheliomatous cancers in this
study, and gliomas with entrapped neu-
rons.33 A common clinical feature of gan-
glioglioma is chronic epilepsy,34 yet only
1 case patient with this histologic type
reported a (12-year) history of epi-
lepsy. Information was obtained on the
follow-up care of 2 surgical case pa-
tients with ganglioglioma. Both re-
ceived postoperative care at a different
institution and were diagnosed as hav-
ing glioma by a second neuropatholo-
gist. There were no diagnoses of neuro-
epitheliomatous cancers at some of the
study centers, which could reflect hos-
pital referral patterns. The ongoing case-
control study of brain cancer in Swe-
den is population-based; however, there
were no case patients with neuronal tu-
mors. Histologic-specific risks accord-
ing to cellular telephone use should be
tested in other study populations.
Recent health risk assessments of RF
fields emitted from mobile telephones
are based on epidemiology, experimen-
tal findings, and studies of RF field in-
teractions with biological tissue.35,36
Based on a review of the literature, oth-
ers concluded that there are few stud-
ies of well-characterized RF energy ex-
posure and cancer in humans, although
the evidence suggests a weak or a lack
of association.37,38 Reviews of in-vitro
studies concluded that a genotoxic po-
tential of RF fields has not been dem-
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onstrated,39,40 and it was recently ar-
gued that the energy levels from cellular
telephone emissions are too low to ini-
tiate or promote cancer.41 However,
some experimental data do demon-
strate biological events occurring after
exposure to RF fields. Microwave radia-
tion was reported to increase single-
strand DNA breaks in rat brain cells,42
although this finding was not con-
firmed elsewhere.43 The incidence of
lymphoma was increased following
whole-body RF irradiation in a trans-
genic animal model,44 but other animal
studies involving RF exposure to the
head found no increase45 or decrease46
in brain tumors. If RF energy from cel-
lular telephones is tumorigenic, it might
act as a promoter or in the progression
phase of cancer.16 The current study
shows no effect with short-term expo-
sure to cellular telephones that operate
on (primarily) analog signals. Further
studies are needed to account for longer
induction periods, especially for slow-
growing tumors. The RF fields emitted
from digital cellular telephones might
have different effects on biological tis-
sue than analog telephones,47 and stud-
ies are under way in several European
countries that use primarily digital tele-
communication networks.
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difference in results. The panel made 2 suggestions concern-
ing the analysis of our 5.5-year test scores: (1) the use of raw
test scores instead of standardized scores and the inclusion
of the child’s age at testing as an additional covariate in the
analysis would provide better control for the age of the child
at testing; and (2) adjustment for which of the 3 staff mem-
bers administered the test battery would improve the preci-
sion of the analysis.
Methods. In the original study, all children were tested at a
mean (SD) age of 66 (6) months and standardized test scores
afforded inherent control for age, and intertester reliability
among the 3 testers was consistently high. We reanalyzed the
data from the 6 primary end points at 66 months, using the
same statistical procedures reported earlier, except that raw test
scores were used, and age at testing and tester were included
as additional covariates in the regression analyses.
Results. The reanalyses confirmed our previous findings. The
TABLE summarizes the results in the same format as our earlier
report.1 The significance and direction of the parameter esti-
mates for prenatal and postnatal exposure are nearly identical
to those reported earlier. We did find significant effects of both
age at testing (to be expected since scores were no longer scaled)
and tester (not unlikely since testers did not have 100%
agreement). There continues to be an association among both
prenatal and postnatal exposure and the Preschool Language Scale
Total Score, as well as an association in males only among post-
natal exposure and scores on the Woodcock-Johnson Applied
Problems and the Bender Gestalt drawing and copying errors.
Comment. These associations continue to suggest benefi-
cial effects with increasing mercury levels that may reflect di-
etary benefits of fish consumption. In a population exposed to
MeHg from consumption of ocean fish, we continue to find no
evidence of adverse effects.
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CORRECTION
Incorrect Hospital Name, Incorrect Numbers, and Rounding Errors: In the Origi-
nal Contribution entitled “Handheld Cellular Telephone Use and Risk of Brain Can-
cer” published in the December 20, 2000, issue of THE JOURNAL (2000;284:3001-
3007), a hospital was identified incorrectly, incorrect statistics appeared in the
“Methods” section, and rounding errors appeared in 2 of the tables. On page 3001,
Dr Neugut’s affiliation should have read “Department of Medicine, Mailman School
of Public Health, Columbia University, New York, NY.” On page 3002, the first
sentence in the “Methods” section should have read “New York Presbyterian Hos-
pital” not “Columbia University Presbyterian Hospital.” Also on page 3002, the
second to last sentence in the second column should have been “In the first 2 years
of the study, 100 of the case interviews (21%) and 22 of the control interviews
(5%) were conducted with proxies.” Also on page 3003, in Table 2, the corre-
sponding values for “Musculoskeletal disorder” should have been “71 (23.9).”
On page 3005, in Table 4, the corresponding values for “No. (%) Who Ever Used
a Cellular Telephone” for “Cerebrum (not lobes)” should have been “36 (5.6).”
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